A prospective longitudinal study of health-related quality of life and psychological wellbeing after an implantable cardioverter-defibrillator in patients with genetic heart diseases

[1]  C. Allaart,et al.  Recurrent Ventricular Arrhythmias and Mortality in Cardiac Arrest Survivors with a Reversible Cause With and Without an Implantable Cardioverter Defibrillator: a Systematic Review. , 2022, Resuscitation.

[2]  D. Moser,et al.  Multi-morbidity burden, psychological distress, and quality of life in implantable cardioverter defibrillator recipients: Results from a nationwide study. , 2019, Journal of psychosomatic research.

[3]  A. Strömberg,et al.  Factors associated with health-related quality of life among cardiac arrest survivors treated with an implantable cardioverter-defibrillator. , 2018, Resuscitation.

[4]  N. Rottmann,et al.  Psychological distress in patients with an implantable cardioverter defibrillator and their partners. , 2018, Journal of psychosomatic research.

[5]  J. Atherton,et al.  Psychosocial Implications of Living with Catecholaminergic Polymorphic Ventricular Tachycardia in Adulthood , 2018, Journal of Genetic Counseling.

[6]  G. Boriani,et al.  Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators , 2018, Circulation. Arrhythmia and electrophysiology.

[7]  T. Potpara,et al.  Patients’ knowledge and attitudes regarding living with implantable electronic devices: results of a multicentre, multinational patient survey conducted by the European Heart Rhythm Association , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[8]  H. Calkins,et al.  Quality of life metrics in arrhythmogenic right ventricular cardiomyopathy patients: The impact of age, shock and sex. , 2017, International journal of cardiology.

[9]  J. Denollet,et al.  Prevalence and risk markers of early psychological distress after ICD implantation in the European REMOTE-CIED study cohort. , 2017, International journal of cardiology.

[10]  J. Denollet,et al.  Posttraumatic stress and anxiety in patients with an implantable cardioverter defibrillator: Trajectories and vulnerability factors , 2017, Pacing and clinical electrophysiology : PACE.

[11]  K. Ball,et al.  Impact of the implantable cardioverter defibrillator on confidence to undertake physical activity in inherited heart disease: A cross-sectional study , 2017, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.

[12]  M. Wong,et al.  Factors associated with anxiety and depression among patients with implantable cardioverter defibrillator , 2017, Journal of clinical nursing.

[13]  S. Sears,et al.  Longitudinal changes in quality of life following ICD implant and the impact of age, gender, and ICD shocks: observations from the INTRINSIC RV trial , 2017, Journal of Interventional Cardiac Electrophysiology.

[14]  E. Ashley,et al.  Interdisciplinary psychosocial care for families with inherited cardiovascular diseases. , 2016, Trends in cardiovascular medicine.

[15]  A. Wilde,et al.  Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: A systematic review and meta-analysis of inappropriate shocks and complications. , 2016, Heart rhythm.

[16]  S. Willich,et al.  Quality of Life in Patients with an Implantable Cardioverter Defibrillator: A Systematic Review , 2015, Front. Cardiovasc. Med..

[17]  A. Strömberg,et al.  Characteristics associated with anxiety, depressive symptoms, and quality-of-life in a large cohort of implantable cardioverter defibrillator recipients. , 2014, Journal of psychosomatic research.

[18]  C. Semsarian,et al.  Psychological wellbeing and posttraumatic stress associated with implantable cardioverter defibrillator therapy in young adults with genetic heart disease. , 2013, International journal of cardiology.

[19]  E. Behr,et al.  Genetic testing for inherited cardiac disease , 2013, Nature Reviews Cardiology.

[20]  L. Jordaens,et al.  Pre-implantation psychological functioning preserved in majority of implantable cardioverter defibrillator patients 12 months post implantation. , 2013, International journal of cardiology.

[21]  D. Mark,et al.  Educational and Psychological Interventions to Improve Outcomes for Recipients of Implantable Cardioverter Defibrillators and Their Families: A Scientific Statement From the American Heart Association , 2012, Circulation.

[22]  N. Blom,et al.  Psychological Functioning and Disease-Related Quality of Life in Pediatric Patients With an Implantable Cardioverter Defibrillator , 2012, Pediatric Cardiology.

[23]  H. Calkins,et al.  General and Disease-Specific Psychosocial Adjustment in Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy With Implantable Cardioverter Defibrillators: A Large Cohort Study , 2012, Circulation. Cardiovascular genetics.

[24]  Emily A. Kuhl,et al.  The prevalence of anxiety and depression in adults with implantable cardioverter defibrillators: a systematic review. , 2011, Journal of psychosomatic research.

[25]  Phillip Wise,et al.  Socio-economic indexes for areas: Getting a handle on individual diversity within areas , 2011 .

[26]  F. Sacher,et al.  The psychological impact of implantable cardioverter defibrillator implantation on Brugada syndrome patients. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[27]  D. Hayes,et al.  Psychopathology in Patients with ICDs over Time: Results of a Prospective Study , 2010, Pacing and clinical electrophysiology : PACE.

[28]  S. Gottlieb,et al.  Changes in psychosocial distress in outpatients with heart failure with implantable cardioverter defibrillators. , 2009, Heart & lung : the journal of critical care.

[29]  A. Tsiatis,et al.  Quality of life with defibrillator therapy or amiodarone in heart failure. , 2008, The New England journal of medicine.

[30]  R. Passman,et al.  Implantable cardioverter defibrillators and quality of life: results from the defibrillators in nonischemic cardiomyopathy treatment evaluation study. , 2007, Archives of Internal Medicine.

[31]  M. Link,et al.  Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. , 2007, JAMA.

[32]  A. Moss,et al.  Health-Related Quality of Life Consequences of Implantable Cardioverter Defibrillators: Results From MADIT II , 2007, Medical care.

[33]  R. Osborne,et al.  The SF36 Version 2: critical analyses of population weights, scoring algorithms and population norms , 2007, Quality of Life Research.

[34]  Emily A. Kuhl,et al.  Measurement of Patient Fears About Implantable Cardioverter Defibrillator Shock: An Initial Evaluation of the Florida Shock Anxiety Scale , 2006, Pacing and clinical electrophysiology : PACE.

[35]  E. Sigurdsson,et al.  Health-related quality of life of patients with implantable cardioverter defibrillators compared with that of pacemaker recipients. , 2006, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[36]  B. Fridlund,et al.  Long-term quality of life and uncertainty in patients living with an implantable cardioverter defibrillator. , 2005, Heart & lung : the journal of critical care.

[37]  S. Sears,et al.  Measuring Patient Acceptance of Implantable Cardiac Device Therapy: , 2005, Journal of cardiovascular electrophysiology.

[38]  C. Sherbourne,et al.  The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .

[39]  R. Snaith,et al.  Doctors and overpopulation , 1986 .

[40]  A. Zigmond,et al.  The Hospital Anxiety and Depression Scale , 1983, Acta psychiatrica Scandinavica.

[41]  J. Morgan,et al.  Validity and reliability of the Hospital Anxiety and Depression Scale in a hypertrophic cardiomyopathy clinic: the HADS in a cardiomyopathy population. , 2006, General hospital psychiatry.

[42]  J. Ware,et al.  Interpreting SF&-36 summary health measures: A response , 2004, Quality of Life Research.

[43]  Ware J.E.Jr.,et al.  THE MOS 36- ITEM SHORT FORM HEALTH SURVEY (SF- 36) CONCEPTUAL FRAMEWORK AND ITEM SELECTION , 1992 .